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ABSTRACT 
A unique feature of topical drug delivery is the direct accessibility of the skin as a target organ for diagnosis and treatment. Among the various groups of 
semisolid preparations, the use of gels has expanded both in cosmetics and in pharmaceutical preparations. Despite of several advantages of gels there is a 
limitation in delivery of hydrophobic drug moiety. This limitation can be overcome by the use of novel topical drug delivery i.e, emulgel. When gel and 
emulsion are used in combined form the dosage form are referred as emulgel. The presence of a gelling agent in the water phase converts a classical emulsion 
into an emulgel. The major objective behind this formulation is delivery of hydrophobic drugs to systemic circulation via skin. Emulgels show dual release 
control system i.e. gel and emulsion. These emulgel are having major advantages on novel vesicular systems as well as on conventional systems in various 
aspects.  Emulgels  for  dermatological  use  have  several  favourable  properties  such  as  being  thixotropic,  greaseless,  easily  spreadable,  easily  removable, 
emollient, non-staining, water-soluble, longer shelf life, bio-friendly, transparent & pleasing appearance. Various permeation enhancers can potentiate the 
effect, So emulgels can be used as better topical drug delivery systems over present systems. The use of emulgels can be extended in analgesics, antifungal 
drugs and various cosmetic formulations. 
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INTRODUCTION 
Topical drug delivery can be defined as the application of a 
drug  containing  formulation  to  the  skin  to  directly  treat 
cutaneous  disorder
1,2.  Topical  drug  administration  is  a 
localized drug delivery system anywhere in the body through 
ophthalmic, rectal, vaginal and skin as topical routes. These 
apply a wide spectrum of preparations for both cosmetic and 
dermatological,  to  their  healthy  or  diseased  skin
3.  Topical 
drug  delivery  is  an  attractive  route  for  local  and  systemic 
treatment
4.  Topical  preparations  pertain  to  medicaments 
applied to the surface of a part of the body and is a term used 
to describe formulations that have effects only in a specific 
area of the body and are formulated in such a manner that the 
systemic absorption of the medicament is minimal
5. Topical 
drug  delivery  offers  several  advantages  over  conventional 
routes
6,7.  It  avoids  the  first-pass  metabolism  and  the 
gastrointestinal  tract.  Topical  delivery  has  the  potential  for 
sustained and controlled drug release. Moreover, it is a non-
invasive  mode  of  drug  delivery  with  no  trauma  or  risk  of 
infection
8.  The  most  common  examples  of  Topical  dosage 
forms  include  solutions,  suspensions,  emulsions  (e.g., 
lotions), semisolids (e.g., foams, ointments, pastes, creams, 
and gels), solids (e.g., powders and aerosols), and sprays
9. 
Within the major group of semisolid preparations, the use of 
transparent  gels  has  expanded  both  in  cosmetics  and  in 
pharmaceutical preparations. Gels are a relatively newer class 
of dosage  form  created by  entrapment of large amounts of 
aqueous or hydro alcoholic liquid in a network of colloidal 
solid particles. In spite of many advantages offered by gels a 
major limitation is in the delivery of hydrophobic drugs. So 
this drawback can be overcome by using an emulsion based 
approach  where  gels  &  emulsions  are  combined  to  form 
EMULGEL
10. Both oil-in water and water-in-oil emulsions 
are used as vehicles to deliver various
 drugs to the skin. In 
recent years, there has been great interest in the use of novel 
polymers  with  complex  functions  as  emulsifiers  and 
thickeners because the gelling capacity of these compounds 
allows  the  formulation  of  stable  emulsions  and  creams  by 
decreasing  surface  and  interfacial  tension  and  at  the  same 
time  increasing  the  viscosity  of  the  aqueous  phase.  The 
presence  of  a  gelling  agent  in  the  water  phase  converts  a 
classical  emulsion  into  an  emulgel
11.  Emulgels  for 
dermatological use have several favorable properties such as 
being  thixotropic,  greaseless,  easily  spreadable,  easily 
removable,  emollient,  nonstaining,  long  shelf  life,  bio-
friendly, transparent & pleasing appearance
3. 
FORMULATION CONSIDERATIONS
12 
The challenges in formulating topical emulgels are: 
1.  Determining  systems  that  are  non-toxic,  non-irritating, 
non-comedogenic and non-sensitizing. 
2. Formulating cosmetically elegant emulgel. 
3.The emulgel formulation must have low allergic potential, 
good physiological compatibility and high biocompatibility. 
ADVANTAGES  OF  EMULGELS  AS  A  TOPICAL 
DRUG DELIVERY
13,14,11 
1. In comparison to the other topical preparations emulgels 
are more stable.  
2.  Hydrophobic  drugs  can  be  easily  incorporated  into  gels 
using the o/w emulsions. 
3. Emulgels exibit Production feasibility and low preparation 
cost. 
4.Emulgels exibit Better loading capacity in comparison to 
other novel approaches like niosomes and liposomes which 
are of nano size and due to vesicular structures may result in 
leakage and result in lesser entrapment efficiency. But gels 
due  to  vast  network  have  comparatively  better  loading 
capacity.  
RATIONALE  
Various types of topical formulations are available or used to 
apply  on  to  the  skin  or  mucous  membrane  restores  a 
fundamental function of skin or pharmacologically alters an  
action in the underlined tissues. On the same time the topical 
agents  such  as  ointment,  cream,  lotion  have  many 
disadvantages also. They are sticky causing uneasiness to the 
patient & also have lesser spreading coefficient and need to 
apply  with  rubbing.  They  exhibit  the  problem  of  stability 
also.  Due  to  all  these  factors  within  the  major  group  of 
semisolid  preparations,  the  use  of  transparent  gels  has 
expanded  both  in  cosmetics  and  in  pharmaceutical 
preparations.  Despite  of  offering  several  benefits  Gels  a Bhatt Preeti et al. IRJP 2013, 4 (2) 
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colloid system shows a  major limitation in the delivery  of 
hydrophobic  drugs.  So  to  overcome  this  limitation  an 
emulsion  based  approach  is  being  used  so  that  even  a 
hydrophobic  therapeutic  moiety  can  be  successfully 
incorporated and delivered through gels. 
SITE OF DRUG DELIVERY 
Skin 
The  skin  is  one  of  the  most  important  parts  of  the  body 
because it interfaces with the environment and is the first line 
of defence from external factors. For example, the skin plays 
a  key  role  in  protecting  the  body  against  pathogens
15 and 
excessive  water  loss
16.   Its  other  functions 
are insulation, temperature  regulation,  sensation,  and  the 
production of vitamin D folates. 
Skin performs the following functions
15-18: 
Protection:  an  anatomical  barrier  from pathogens and 
damage  between  the  internal  and  external environment in 
bodily  defence; Langerhans  cells in  the  skin  are  part  of 
the adaptive immune system
15,16. 
Sensation: contains a variety of nerve endings that jump to 
heat  and  cold,  touch,  pressure,  vibration,  and  tissue  injury 
(see somato-sensory system and haptic perception). 
Thermoregulation: eccrine (sweat) glands and dilated blood 
vessels (increased superficial perfusion) aid heat loss, while 
constricted vessels greatly  reduce  cutaneous blood  flow and 
conserve heat. 
Control  of evaporation:  the  skin  provides  a  relatively  dry 
and semi-impermeable barrier to fluid loss
16. 
Storage  and synthesis:  acts  as  a  storage  centre 
for lipids and water. 
Absorption: oxygen, nitrogen and carbon dioxide can diffuse 
into the epidermis in small amounts; some animals use their 
skin  as  their  sole respiration  organ (in humans,  the cells 
comprising  the  outermost  0.25–0.40 mm  of  the  skin  are 
"almost exclusively supplied  by  external oxygen", although 
the "contribution to total respiration is negligible")
17. 
Water resistance: The skin acts as a water resistant barrier 
so  essential nutrients aren't  washed  out  of  the body.  The 
nutrients and oils that help hydrate our skin are covered by 
our  most  outer  skin  layer,  the epidermis.  This  is  helped  in 
part  by  the  sebaceous  glands  that  release  sebum,  an  oily 
liquid. Water itself will not cause the elimination of oils on 
the  skin,  because  the  oils  residing  in  our  dermis  flow  and 
would be affected by water without the epidermis
18. 
SKIN ANATOMY 
Epidermis 
The epidermis is  composed  of  the  outermost  layers  of  the 
skin.  It  forms  a  protective  barrier  over  the body's  surface, 
responsible  for  keeping  water  in  the  body  and 
preventing pathogens from  entering,  and  is  a  stratified 
squamous epithelium
19, composed  of proliferating basal 
and differentiated suprabasal keratinocytes. 
Keratinocytes  are  the  major  cells,  constituting  95%  of  the 
epidermis
19, while Merkel cells, melanocytes and Langerhans 
cells  are  also  present.  The  epidermis  can  be  further 
subdivided into the following strata or layers (beginning with 
the outermost layer)20. 
·  Stratum corneum 
·  Stratum lucidum (only in palms and soles) 
·  Stratum granulosum 
·  Stratum spinosum 
·  Stratum germinativum (also called the stratum basale) 
The epidermis contains  no blood  vessels,  and cells in  the 
deepest  layers  are  nourished  by  diffusion 
from blood capillaries extending  to  the  upper  layers  of 
the dermis. 
Dermoepidermal junction/basement membrane 
This  is  a  complex  structure  composed  of  two  layers.  The 
structure is highly irregular, with dermal  papillae  from the 
papillary dermis projecting perpendicular to the skin surface. 
It is via diffusion at this junction that the epidermis obtains 
nutrients  and  disposes  of  waste.  The  dermoepidermal 
junction  flattens  during  ageing  which  accounts  in  part  for 
some of the visual signs of ageing
21. 
Dermis 
The dermis is the layer  of skin beneath the epidermis that 
consists  of  connective  tissue  and  cushions  the  body  from 
stress  and  strain.  The  dermis  provides  tensile  strength  and 
elasticity  to  the  skin  through  an  extracellular  matrix 
composed of collagen fibrils, microfibrils, and elastic fibers, 
embedded in proteoglycans
22. The dermis is tightly connected 
to  the  epidermis  through  a  basement  membrane  and  is 
structurally divided into two areas: a superficial area adjacent 
to  the  epidermis,  called  the  papillary  region,  and  a  deep 
thicker area known as the reticular region. 
Hypodermis 
The hypodermis is not part of the skin, and lies below the 
dermis. Its purpose is to attach the skin to underlying bone 
and muscle as well as supplying it with blood  vessels  and 
nerves. It consists of loose connective tissue and elastin.   
The  main  cell  types  are  fibroblasts,  macrophages  and 
adipocytes (the hypodermis contains 50% of body fat). Fat 
serves as padding and insulation for the body. Another name 
for the hypodermis is the subcutaneous tissue. 
FACTORS TO BE CONSIDERED WHEN CHOOSING 
A TOPICAL PREPARATION
23-24 
1. Effect of the  vehicle  e.g. an  occlusive  vehicle enhances 
penetration  of  the  active  ingredient  and  improves  efficacy. 
The vehicle itself may have a cooling, drying, emollient or 
protective action. 
2. Match the type of preparation with the type of lesions. For 
example, avoid greasy ointments for acute weepy dermatitis. 
3. Match the type of preparation with the site. (e.g., gel or 
lotion for hairy areas) 
4.  Irritation  or  sensitization  potential.  Generally,  ointments 
and w/o creams are less irritating, while gels are irritating. 
Ointments  do  not  contain  preservatives  or  emulsifiers  if 
allergy to these agents is a concern. 
ADDITIVES  /  EXEPIENTS  USED  IN  EMULGEL 
FORMULATION
 
Ideal Properties of Additives 
1.  They must be non toxic. 
2.  They must be commercially available in acceptable grade. 
3.  Their cost must be acceptably cheap. 
4.  They must not be contraindicated. 
5.  They  must  be  physically  and  chemically  stable  by 
themselves  and  in  combination  with  drugs  and  other 
components. 
6.  They must be colour compatible. 
1. Aqueous Material & oils 
This  forms the aqueous  phase  of the emulsion. Commonly 
used agents are water, alcohols. Oils form the oily phase if 
the emulsion. Widely used oils in oral preparations are non-
biodegradable mineral and castor oils which provides a local 
laxative  effect,  and  fish  liver  oils  or  various  fixed  oils  of 
vegetable origin (e.g., arachis, cottonseed, and maize oils) as 
nutritional supplements
25. 
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2. Emulsifiers: 
Emulsifying agents are used both to promote emulsification 
at the time of manufacture and to control stability during a 
shelf  life  that  can  vary  from  days  for  extemporaneously 
prepared  emulsions  to  months  or  years  for  commercial 
preparations  e.g.  Polyethylene  glycol  40  stearate,  Sorbitan 
mono-oleate (Span 80), Polyoxyethylene sorbitan monooleate 
(Tween 80), Stearic acid and Sodium stearate
26. 
4. Gelling Agent:  
These  are  used  to  increase  the  consistency  of  any  dosage 
form.  they  can  also  be  used  as  thickening  agent
27.
  The 
examples are given in table 2 & 3.
 
5. Permeation Enhancers:  
These  are  agents  that  partition  into,  and  interact  with  skin 
constituents to induce a temporary and reversible increase in 
skin permeability. Some of these materials are given in Table 
4
28. 
MECHANISM OF PENETRATION ENHANCERS: 
The enhancers act by altering one of three pathways. The key 
to  altering  the  polar  pathway  is  to  cause  protein 
conformational  change  or  solvent  swelling.  The  fatty  acid 
enhancers increased the fluidity of the lipid protein portion of 
the stratum corneum. Some enhancers act on both polar and 
non-polar pathway by altering the multi laminate pathway for 
penetration.  Enhancers  can  increase  the  drug  diffusivity 
through skin proteins. The type of enhancer employed has a 
significant  impact  on  the  design  and  development  of  the 
product
29. 
METHOD OF PREPARATION
30-32 
Step 1: Formulation of Emulsion either O/W or W/O 
Step 2: Formulation of gel base 
Step  3:  Incorporation  of  emulsion  into  gel  base  with 
continuous stirring
 
Emulgel  was  prepared  by  the  method  reported  by 
Mohammad et al (2004) with minor modification. The Gel in 
formulations  were  prepared  by  dispersing  Carbopol  934  in 
purified water with constant stirring at a moderate speed and 
Carbopol  940  in  purified  water  with  constant  stirring  at  a 
moderate speed then the pH are adjusted to 6 to 6.5 using Tri 
ethanol  amine  (TEA).  The  oil  phase  of  the  emulsion  were 
prepared by dissolving Span 20 in light liquid paraffin while 
the aqueous phase was prepared by dissolving Tween 20 in 
purified water. Methyl and Propyl paraben was dissolved in 
propylene glycol whereas drug was dissolved in ethanol and 
both solutions was mixed with the aqueous phase. Both the 
oily  and  aqueous  phases  were  separately  heated  to  70°  to 
80°C; then the oily phase were added to the aqueous phase 
with  continuous  stirring  until  cooled  to  room  temperature. 
And  add  Glutaraldehyde  in  during  of  mixing  of  gel  and 
emulsion in ratio 1:1 to obtain the emulgel
32. 
EVALUATION  PARAMETERS  FOR  THE 
FORMULATION 
30,33-37 
1. Organoleptic properties 
The prepared emulgel formulations are inspected visually for 
their color, homogeneity, consistency and phase separation. 
2. Rheological Studies 
The  viscosity  of  the  different  emulgel  formulations  is 
determined at 25°C using a cone and plate viscometer with 
spindle  52  (Brookfield  Engineering  Laboratories,)  and 
connected to a thermostatically controlled circulating water 
bath. 
3. Spreading Coefficient: 
Spreadibility  is  determined  by  apparatus  suggested  by 
Mutimer et al (1956) which is 
suitably modified in the laboratory and used for the study. It 
consists of a wooden block, which is provided by a pulley at 
one  end.  By  this  method,  spreadibility  is  measured  on  the 
basis  of  ‘Slip’  and  ‘Drag’  characteristics  of  emulgels.  A 
ground  glass  slide  is  fixed  on  this  block.  An  excess  of 
emulgel (about 2 gm) under study is placed on this ground 
slide. The emulgel is then sandwiched between this slide and 
another  glass  slide  having  the  dimension  of  fixed  ground 
slide and provided with the hook. A 1 Kg weight is placed on 
the top of the two slides for 5 minutes to expel air and to 
provide  a  uniform  film  of  the  emulgel  between  the  slides. 
Excess of the emulgel is scrapped off from the edges. The top 
plate is then subjected to  pull of 80 gm. With the help  of 
string attached to the hook and the time (in seconds) required 
by the top slide to cover a distance of 7.5 cm be noted. A 
shorter interval indicates better spreadibility
37. 
5. Swelling Index: 
To determine the swelling index of prepared topical emulgel, 
1 gm of gel is taken on porous aluminum foil and then placed 
separately in a 50 ml beaker containing 10 ml 0.1 N NaoH. 
Then samples were removed from beakers at different time 
intervals  and  put  it  on  dry  place  for  some  time  after  it 
reweighed. Swelling index is calculated as follows: 
Swelling Index (SW) % = [(Wt – Wo) / Wo] × 100. 
Where (SW) % = Equilibrium percent swelling, 
Wt = Weight of swollen emulgel after time t, 
Wo = Original weight of emulgel at zero time
38. 
6. Drug Content Determination: 
Take 1gm of emulgel. Mix it in suitable solvent. Filter it to 
obtain  clear  solution.  Determine  its  absorbance  using  UV 
spectrophotometer. Standard plot of drug is prepared in the 
same  solvent.  Concentration  and  drug  content  can  be 
determined by using the same standard plot  by  putting the 
value of absorbance in the standard plot equation: 
Drug Content = (Concentration × Dilution Factor × Volume 
taken) × Conversion Factor. 
7. Skin Irritation Test (Patch Test): 
The preparation is applied on the properly shaven skin of rat 
and its adverse effect like  change in color, change in skin 
morphology should be checked up to 24 hours. The total set 
of 8 rats can be used of the study. If no irritation occurs the 
test is passed. If the skin irritation symptom occurs in more 
than 2 rats the study should be repeated. 
9. In Vitro Release/Permeation Studies: 
In vitro release studies were carried out using Franz diffusion 
cell. 
DRUG RELEASE KINETIC STUDY
39 
To analyze the mechanism of drug release from the topical 
gel, the release data were fitted to following equations 
Zero – order equation: 
Q = k 0t 
Where Q is the amount of drug released at time t, and k0 is 
the zero – order release rate. 
First – order equation: 
In (100 – Q) = In 100 – k1t 
Where Q is the percent of drug release at time t, and k1 is the 
first – order release rate constant. 
Higuchi’s equation: 
Q = k2√t 
Where Q is the percent of drug release at time t, and K2 is the 
diffusion rate constant. 
10. Stability Studies: 
The prepared emulgels were packed in aluminum collapsible 
tubes (5 g) and subjected to stability studies at 5°C, 25°C/ 
60% RH, 30°C/65% RH, and 40°C/75% RH for a period of 3 Bhatt Preeti et al. IRJP 2013, 4 (2) 
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months.  Samples  were  withdrawn  at  15-day  time  intervals 
and  evaluated  for  physical  appearance,  pH,  rheological 
properties, drug content, and drug release profiles. 
 
TABLE 1 FACTORS AFFECTING TOPICAL ABSORPTION OF DRUG
[40, 41] 
Physiological factors  Physiochemical factors 
Skin thickness  Partition coefficient 
Lipid content  Molecular weight (<400 dalton) 
Skin ph  Degree of ionization ( unionized drug get adsorbed well) 
Density of hair follicles & sweat glands  Effect of vehicles 
Blood flow   
Hydration  & inflammation of skin   
 
TABLE 2. USE OF DIFFERENT GELLING AGENTS
 
Gelling agents  Quantity  Dosage form  References 
Carbopol 934  1%  Emulgel  Mohamed, M.I.,AAPS 
Carbopol 940  1%  Emulgel  Jain, Ankur. IJPRD 
HPMC 2910  2.5%  Emulgel  Mohamed, M.I.,AAPS 
HPMC  3.5%  Gel  Gupta,A.,Drug Invention Today 
Poloxamer 407  1%  Gel  Singh,S.,Pak J. Pharm. Sci. 
 
TABLE 3. DIFFERENT GRADES OF CARBOPOL 
Polymer  Viscosity  Properties 
Carbopol 910  3000-7000  Effective in low concentrations and will provide a low viscosity formulation 
Carbopol 934  30,500-
39,400 
Effective in thick formulations such as emulsions, suspensions, sustain release formulations, transdermals, and 
topicals forms clear gels with water. 
Carbopol 934 P 
 
29,400-
39,400 
Same properties as 934, but intended for pharmaceutical formulation purified product. 
Carbopol 940  40,000-
60,000 
Effective in thick formulations, very good clarity in water or hydro alcoholic topical gels. Form clear gels with 
hydro alcoholic systems. 
Carbopol 940  4,000-11,000  Produces low viscosity gels, very good clarity. 
 
TABLE 4. USE OF PENETRATION ENHANCERS
 
Permeation enhancers  Quantity  Dosage form  References 
Oleic acid  1%  Gel  Mortazavi, S.A., Iranian Journal, of Pharmaceutical Science
 
Lecithin  5%  Gel
  Mortazavi, S.A., Iranian Journal, of Pharmaceutical Science
 
Eucalyptus oil  NA  None  Pathan, I.B.,Trop J Pharm Res. 
Chenopodium oil  NA  None
  Pathan, I.B.,Trop J Pharm Res. 
Isopropyl myristate  5%  Gel
  Mortazavi, S.A., Iranian Journal, of Pharmaceutical Science
 
Urea  10%  Gel
  Mortazavi, S.A., Iranian Journal, of Pharmaceutical Science
 
Linoleic acid  5%  Gel
  Kasliwal, N., AJPS 
 
 
 
Figure 1 The layers of skin
 
 
 
CONCLUSION 
In  the  recent  years,  topical  drug  delivery  will  be  used 
extensively due to better patient compliance. Since emulgel 
had appeared as a new & novel technique for topical drug 
delivery  so  it  can  be  a  very  effective  technique  for 
hydrophobic  drugs.  Since  It  is  also  capable  in  enhancing 
spreadibility,  adhesion,  viscosity  and  extrusion,  they  will 
become a popular drug delivery system. Moreover, they will 
become a solution for loading hydrophobic drugs in a water 
soluble gel bases. 
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